• Lipoprotein Associated Phospholipase A2 (PLAC)
  • Coccidioides Antibody, IgG
  • C1 Esterase Inhibitor, Antigen
  • AIP gene mutation analysis
  • Follicle Stimulating Hormone (FSH)
  • Coccidioides Antigen
  • Ganglioside (Asialo-GM1, GM1, GM2, GD1a, GD1b, and GQ1b) Antibodies
  • TNNI3 (Troponin I) Gene Mutation Analysis
  • Ribonucleoprotein P (U1RNP) Antibody (ENA)
  • p16 by Immunohistochemistry (CINtecĀ® and CINtecĀ® PLUS Cytology)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Human Papillomavirus (HPV) Typing, DNA In Situ Hybridization
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Human Papillomavirus (HPV) Typing, DNA In Situ Hybridization
Medical Test

Methodology
Access to Human Papillomavirus (HPV) Typing, DNA In Situ Hybridization is restricted.
Loading...